Prescription drug · BLA
Panhematin (Hemin) NDC 55292-702
Hemin 7 mg/mL · Powder, For solution · Intravenous · Recordati Rare Diseases, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55292-702-55 | 55292070255 | 1 VIAL in 1 CARTON (55292-702-55) / 48 mL in 1 VIAL (55292-702-54)Marketed from Jul 20, 1983 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Panhematin
- Generic name (nonproprietary)
- hemin
- Active ingredients
- Hemin — 7 mg/mL
- Dosage form
- Powder, For solution
- Route
- Intravenous
- Labeler
- Recordati Rare Diseases, Inc.NDC labeler code 55292
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 101246
- Marketing start
- Listing expires
- Identifiers
- Product ID 55292-702_ff0139fe-eb46-4d22-95f1-849de7ce9462SPL ID ff0139fe-eb46-4d22-95f1-849de7ce9462SPL set ID 9984267a-4d57-4444-9bb5-16bca7dea691RxCUI 1926452, 1926454UNII 743LRP9S7N
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455292070255followed by a unit qualifier and the quantityPackage 55292-0702-55. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
PANHEMATIN is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be inadequate. Limitations of Use • Before administering PANHEMATIN, consider an appropriate period of carbohydrate loading (i.e., 400 g glucose/day for 1 to 2 days) [ See Dosage and Administration ( 2.1 ) ]. • Attacks of porphyria may progress to a point where irreversible neuronal damage has occurred. PANHEMATIN therapy is intended to prevent an attack from reaching the critical stage of neuronal degeneration. PANHEMATIN is not effective in repairing…
Excerpt only. Read the full label for complete information.
About NDC 55292-702
- What is NDC 55292-702?
- 55292-702 is the product NDC for Panhematin (hemin), Hemin 7 mg/mL powder, for solution, listed with the FDA by Recordati Rare Diseases, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Panhematin (Hemin).
- What is the active ingredient?
- Hemin.
- Who is the labeler?
- Recordati Rare Diseases, Inc., NDC labeler code 55292. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Panhematin?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.